Krishna Institute of Medical Sciences (KIMS) has increased its equity stake in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital), to 75.53%. This increase comes after acquiring an additional 6.94% equity stake. The total investment cost is approximately ₹148.09 Cr. This strategic move reinforces KIMS’ position in its subsidiary.
Increased Holding in Sunshine Hospital
Krishna Institute of Medical Sciences (KIMS) has further invested in Sarvejana Healthcare Private Limited, also known as Sunshine Hospital. As of December 19, 2025, KIMS now holds a 75.53% stake in Sunshine Hospital, strengthening its position in the subsidiary. The company acquired an additional 6.94% of equity shares.
Details of the Acquisition
The additional equity stake of 6.94% in Sunshine Hospital was acquired through secondary purchase. The cost for acquiring this additional equity is around ₹148.09 Cr. Sunshine Hospital’s turnover for the financial year ending March 31, 2025, was ₹597.00 Cr.
Sarvejana Healthcare (Sunshine Hospital) Overview
Sunshine Hospital commenced operations in May 2009, primarily focusing on orthopedic services, particularly joint replacement. It has since expanded to include other high-end healthcare services such as cardiology and transplant services. It is a material subsidiary of KIMS.
Financial Performance
Here’s a look at Sunshine Hospital’s turnover for the past three financial years:
| Particulars | Amount in Crores |
|---|---|
| FY25 | ₹597.00 |
| FY24 | ₹464.20 |
| FY23 | ₹419.44 |
Source: BSE